(Q36985884)

17 August 2017

1 reference

title

Leuprolide acetate: a drug of diverse clinical applications (English)

1 reference

17 August 2017

1 reference

Andrea C Wilson

1

1 reference

17 August 2017

Sivan Vadakkadath Meethal

series ordinal

2

1 reference

17 August 2017

Richard L Bowen

series ordinal

3

1 reference

17 August 2017

Craig S Atwood

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Expert Opinion on Investigational Drugs

17 August 2017

published in

1 reference

17 August 2017

volume

16

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

1851-1863

1 reference

Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Isolation and properties of the FSH and LH-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Antiandrogen treatments in locally advanced prostate cancer: are they all the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Peptide analogs in the therapy of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Effects of leuprolide in the treatment of central precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Long-term GnRH analogue treatment is equivalent to laparoscopic laser diathermy in polycystic ovarian syndrome patients with severe ovarian dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Use of gonadotrophin-releasing hormone agonists to trigger ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Spotlight on bicalutamide 150mg in the treatment of locally advanced prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

An evaluation of the pharmacokinetics and pharmacodynamics of the histrelin implant for the palliative treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Efficacy and safety of histrelin subdermal implant in patients with advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Gonadotropin-releasing hormone and its analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Long-term suppression of fertility in female giraffe using the GnRH agonist deslorelin as a long-acting implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Long-term effects of deslorelin implants on reproduction in the female tammar wallaby (Macropus eugenii).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Use of a new drug delivery formulation of the gonadotrophin-releasing hormone analogue Deslorelin for reversible long-term contraception in male dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Gonadotropin-releasing hormone and the control of gonadotrope function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Control of luteinizing hormone-releasing hormone pulse generation in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Gonadotropin-releasing hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Gonadotropin-releasing hormone and its receptor in normal and malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Gonadotropin-releasing hormone (GnRH) receptor dynamics and gonadotrope responsiveness during and after continuous GnRH stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Clinical pharmacokinetics of depot leuprorelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Hypothalamic hormones and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Hormonal therapy: historical perspective to future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Early versus late hormonal therapy: debating the issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

The role of diethylstilbestrol in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Regular review: Endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Options for medical treatment of myomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Molecular biology of inhibin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Management and outcome of central precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Activin A regulation of gonadotropin-releasing hormone synthesis and release in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Single-dose depot leuprolide is as efficient as daily short-acting leuprolide in ICSI cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Comparison of leuprolide acetate and triptorelin in assisted reproductive technology cycles: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

An association of elevated serum gonadotropin concentrations and Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Clinical and Hormonal Effects of Chronic Gonadotropin Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Management of short stature with GnRH agonist and co-treatment with growth hormone: a controversial issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

A brief review of the addition of gonadotropin-releasing hormone agonists (GnRH-Ag) to growth hormone (GH) treatment of children with idiopathic growth hormone deficiency: Previously published studies from America

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Anabolic steroid and gonadotropin releasing hormone analog combined treatment increased pubertal height gain and adult height in two children who entered puberty with short stature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

A hypersexual paraphilic patient treated with leuprolide acetate: a single case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

Living and dying for sex. A theory of aging based on the modulation of cell cycle signaling by reproductive hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1851

10.1517/13543784.16.11.1851

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference